K251519

Substantially Equivalent

RelieVRx (Pico G3)

Applicant: Appliedvr
Product code: QRA
Advisory panel: Neurology
Date received: 2025-05-16
Decision date: 2025-08-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Van Nuys, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.